Acadia Pharmaceuticals
ACAD
ACAD
307 hedge funds and large institutions have $3.66B invested in Acadia Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 98 increasing their positions, 124 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 317 → 307 (-10)
15% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 54
21% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 124
Holders
307
Holding in Top 10
4
Calls
$19.9M
Puts
$7.8M
Top Buyers
| 1 | +$58.6M | |
| 2 | +$35.4M | |
| 3 | +$25M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13M |
Top Sellers
| 1 | -$42.1M | |
| 2 | -$31.8M | |
| 3 | -$26.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$17.6M |
| 5 |
Two Sigma Advisers
New York
|
-$16.7M |
